Upneeq Solution/ Drops
Product Images NDC 73687-062

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Upneeq (NDC 73687-062). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rvl Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Oxymetazoline Structural Formula (Upneeq 1)

FDA Label Image

Figure G (Upneeq 10)

FDA Label Image

Upneeq 30 Ct Carton (Upneeq 11)

FDA Label Image

Upneeq Trade Foil Pouch (Upneeq 12)

Upneeq Trade Foil Pouch (Upneeq 12)
UPNEEQ is a prescription ophthalmic solution containing 0.1% oxymetazoline hydrochloride for topical use in the eye. The usual dosage is one drop per day, to be discarded immediately after dosing, and the single-use container should be stored between 20°C-25°C. UPNEEQ is sterile and non-preserved, and included in the package is a single 0.3 mL container. The product is manufactured by Pharmaceuticals, Inc. located in Bridgewater, NJ.*
FDA Label Image

Upneeq 13

Upneeq 13
UPNEEQ is a medication containing loymetazoine fydochloride. There is additional text that appears to be a percentage but is not readable.*
FDA Label Image

Table (Upneeq 2)

FDA Label Image

Oxymetazoline Image (Upneeq 3)

FDA Label Image

Figure A (Upneeq 4)

FDA Label Image

Figure B (Upneeq 5)

FDA Label Image

Figure C (Upneeq 6)

FDA Label Image

Figure D (Upneeq 7)

FDA Label Image

Figure E (Upneeq 8)

FDA Label Image

Figure F (Upneeq 9)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.